Medical Management of Uveitis - Current Trends

Overview

Journal Indian J Ophthalmol

Specialty Ophthalmology

Date 2013 Jun 28

PMID 23803479

Citations 15

Authors

Kalpana Babu

Padmamalini Mahendradas

Affiliations

Soon will be listed here.

Abstract

Uveitis is a challenging disease to treat. Corticosteroids have been used in the treatment of uveitis for many years. Immunosuppressives are gaining momentum in recent years in the treatment of uveitis. In this article we present an overview of current treatment of uveitis and the major breakthroughs and advances in drugs and ocular drug delivery systems in the treatment of uveitis.

Citing Articles

Mesenchymal stem cell based therapies for uveitis: a systematic review of preclinical studies.

Kanda P, Gupta A, Dhillon J, Kundapur D, Gottlieb C Eye (Lond). 2024; 38(10):1845-1854.

PMID: 38600361 PMC: 11226430. DOI: 10.1038/s41433-024-03057-6.

Bilateral Acute Retinal Necrosis Treated With Antivirals and Corticosteroids.

Ramirez Marquez E, Santiago A, Mendez I, Santiago J, Lopez-Fontanet J, Garcia N Cureus. 2023; 15(10):e47427.

PMID: 38021535 PMC: 10658967. DOI: 10.7759/cureus.47427.

Oral 5-aminolevulinic acid combined with sodium ferrous citrate prevents blood-aqueous barrier breakdown after anterior chamber paracentesis in healthy beagle dogs.

Otaka Y, Kanai K, Tomatsu A, Sangu R, Okada D, Nagai N J Vet Med Sci. 2023; 85(12):1257-1260.

PMID: 37880141 PMC: 10788171. DOI: 10.1292/jvms.23-0347.

Ocular immunosuppressive microenvironment and novel drug delivery for control of uveitis.

Teabagy S, Wood E, Bilsbury E, Doherty S, Janardhana P, Lee D Adv Drug Deliv Rev. 2023; 198:114869.

PMID: 37172782 PMC: 10330522. DOI: 10.1016/j.addr.2023.114869.

Clinical relationship between dry eye disease and uveitis: a scoping review.

Rojas-Carabali W, Mejia-Salgado G, Cifuentes-Gonzalez C, Villabona-Martinez V, Barraquer-Lopez N, Valdes-Arias D J Ophthalmic Inflamm Infect. 2023; 13(1):2.

PMID: 36715869 PMC: 9886213. DOI: 10.1186/s12348-022-00323-0.

References

Soheilian M, Ramezani A, Azimzadeh A, Sadoughi M, Dehghan M, Shahghadami R . Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis. Ophthalmology. 2010; 118(1):134-41. DOI: 10.1016/j.ophtha.2010.04.020. View

Hatton M, Duker J, Reichel E, Morley M, Puliafito C . Treatment of relapsed cytomegalovirus retinitis with the sustained-release ganciclovir implant. Retina. 1998; 18(1):50-5. DOI: 10.1097/00006982-199801000-00009. View

Lindstedt E, Baarsma G, Kuijpers R, van Hagen P . Anti-TNF-alpha therapy for sight threatening uveitis. Br J Ophthalmol. 2005; 89(5):533-6. PMC: 1772627. DOI: 10.1136/bjo.2003.037192. View

Jabs D, Rosenbaum J, Foster C, Holland G, Jaffe G, Louie J . Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000; 130(4):492-513. DOI: 10.1016/s0002-9394(00)00659-0. View

Riddell 4th J, Comer G, Kauffman C . Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents. Clin Infect Dis. 2011; 52(5):648-53. DOI: 10.1093/cid/ciq204. View

Haller J, Bandello F, Belfort Jr R, Blumenkranz M, Gillies M, Heier J . Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010; 117(6):1134-1146.e3. DOI: 10.1016/j.ophtha.2010.03.032. View

Chee S, Jap A . Cytomegalovirus anterior uveitis: outcome of treatment. Br J Ophthalmol. 2010; 94(12):1648-52. DOI: 10.1136/bjo.2009.167767. View

Jaffe G, Guo H, Dunn J, Ashton P . Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology. 2000; 107(11):2024-33. DOI: 10.1016/s0161-6420(00)00466-8. View

Heiligenhaus A, Miserocchi E, Heinz C, Gerloni V, Kotaniemi K . Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab). Rheumatology (Oxford). 2011; 50(8):1390-4. DOI: 10.1093/rheumatology/ker107. View

10.

Biswas J . Practical concepts in the management of uveitis. Indian J Ophthalmol. 1993; 41(3):133-41. View

11.

Birnbaum A, Jiang Y, Tessler H, Goldstein D . Elevation of intraocular pressure in patients with uveitis treated with topical difluprednate. Arch Ophthalmol. 2011; 129(5):667-8. DOI: 10.1001/archophthalmol.2011.82. View

12.

Kempen J, Altaweel M, Holbrook J, Jabs D, Sugar E . The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. Am J Ophthalmol. 2010; 149(4):550-561.e10. PMC: 2975449. DOI: 10.1016/j.ajo.2009.11.019. View

13.

Cunningham M, Edelman J, Kaushal S . Intravitreal steroids for macular edema: the past, the present, and the future. Surv Ophthalmol. 2008; 53(2):139-49. DOI: 10.1016/j.survophthal.2007.12.005. View

14.

Foster C, DaVanzo R, Flynn T, McLeod K, Vogel R, Crockett R . Durezol (Difluprednate Ophthalmic Emulsion 0.05%) compared with Pred Forte 1% ophthalmic suspension in the treatment of endogenous anterior uveitis. J Ocul Pharmacol Ther. 2010; 26(5):475-83. DOI: 10.1089/jop.2010.0059. View

15.

Posarelli C, Arapi I, Figus M, Neri P . Biologic agents in inflammatory eye disease. J Ophthalmic Vis Res. 2012; 6(4):309-16. PMC: 3306110. View

16.

Bodaghi B, Gendron G, Wechsler B, Terrada C, Cassoux N, Le Thi Huong D . Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients. Br J Ophthalmol. 2006; 91(3):335-9. PMC: 1857681. DOI: 10.1136/bjo.2006.101550. View

17.

Gulati N, Forooghian F, Lieberman R, Jabs D . Vascular endothelial growth factor inhibition in uveitis: a systematic review. Br J Ophthalmol. 2010; 95(2):162-5. DOI: 10.1136/bjo.2009.177279. View

18.

Nozik R . Periocular injection of steroids. Trans Am Acad Ophthalmol Otolaryngol. 1972; 76(3):695-705. View

19.

Cho H, Wolf K, Wolf E . Management of ocular inflammation and pain following cataract surgery: focus on bromfenac ophthalmic solution. Clin Ophthalmol. 2009; 3:199-210. PMC: 2709021. DOI: 10.2147/opth.s4806. View

20.

Bittencourt M, Sepah Y, Do D, Agbedia O, Akhtar A, Liu H . New treatment options for noninfectious uveitis. Dev Ophthalmol. 2012; 51:134-61. DOI: 10.1159/000336338. View